Emmessar Biotech & Nutrition has informed that pursuant to Clause 4 of the Schedule B of Prohibition of Insider Trading Regulations, as amended, of the SEBI [PIT] Regulations, 2015, as amended, The Trading Window for dealing in the securities of the Company, will remain closed with effect from April 01, 2024 till May 31, 2024 for considering the financial results for the quarter / year ending March 31, 2024. Accordingly, all insiders/ designated persons and their relatives are advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.
